Purchase Order HHSN269201600522P
Award Date
6/10/16
Potential Completion Date
6/13/17
Potential Value
$96K
Federal Agency
NIH Clinical Center
Awardee
Profounda Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network (VISN) 20, to Profounda Inc. for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections. The contract, valued at $16,650.00, does not have a set-aside designation and is intended to support the VA's mission of providing healthcare services to veterans by ensuring rapid access to...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $99,900.00, is for the delivery of Miltefosine 50mg tablets, a critical medication used to treat leishmaniasis and other drug-resistant infections. This purchase order is part of a larger $1,127,000 Blanket Purchase Agreement (BPA) held by Profounda Inc. with the VA's...
The U.S. Department of Veterans Affairs (VA) has awarded a $49,950 firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract is for the emergency delivery of 84 tablets of Impavido (Miltefosine) in three packages of 28, to the VA's Oklahoma City VA Medical Center (OKCVAMC) Pharmacy. This purchase order is part of a larger Blanket Purchase Agreement (BPA) valued at $1,127,000 that Profounda Inc. holds...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Profounda Inc., a self-certified small disadvantaged business. The $49,950.00 contract is for the delivery of Profounda's Impavido/Miltefosine pharmaceutical product to the VA Sunshine Healthcare Network (VISN 20) in Orlando, Florida. Impavido/Miltefosine is used to treat leishmaniasis and other drug-resistant infections in veterans. This award is the latest in a...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a $299,700.00 firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business manufacturer of pharmaceutical products, to provide the medication Impavido (miltefosine) to the Puget Sound VA Medical Center. This sole-source procurement is to acquire this specialized drug for treating Disseminated Cutaneous Acanthamboeba, with a performance period from May 1, 2025, to October 30,...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products, for $112,000.00. The contract, which does not have a set-aside designation, is for the delivery of Profounda's pharmaceutical products, with a period of performance through September 19, 2023. Profounda has been awarded numerous...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $16,750 purchase order to Profounda Inc. for the delivery of 50mg miltefosine capsules. The firm fixed price contract runs from December 14, 2023 through January 13, 2024 and will be performed in Omaha, Nebraska. Profounda Inc. will provide the pharmaceutical products to VA-VHA under this contract to support their healthcare services for veterans. No subcontractors or set aside...
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Insmed Inc., a global biopharmaceutical company, for the provision of emergency pharmacy orders. The order, valued at $70,737.80, is for firm fixed-price pharmaceutical products to be delivered by September 30, 2025. The contract is not set aside for any particular business type. Insmed Inc. holds multiple federal contract vehicles with the VA, including a GSA Pharmaceutical and Drugs schedule contract, which allows...
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The $478,860.00 contract is for the delivery of pharmaceutical products, specifically Levodopa 42mg inhalation capsules used to treat Parkinson's disease symptoms. The contract is associated with Acorda's Federal Supply Schedule (FSS) contract with the VA, valued...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 15 (VISN 15), a civilian agency within the Department of Veterans Affairs (VA), to Veterans Healthcare Supply Solutions, Inc., a Service-Disabled Veteran-Owned Small Business (SDVOSB). The contract is for the refill of MiniMed supply items, with an ultimate completion date of April 18, 2016, and a ceiling value of $115,390.00. The contract is not set aside. In addition to this contract, Veterans...